Pharmaceutical Technology Licensing: An Analysis in the Field of Cardiovascular Disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science
Link
http://link.springer.com/content/pdf/10.1007/s12247-015-9234-5.pdf
Reference43 articles.
1. Sheridan C. Industry continues dabbling with open innovation models. Nat Biotechnol. 2012;30(2):193.
2. Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, et al. How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nat Rev Drug Discov. 2010;9:203–14.
3. Talaga P. Open innovation: share or die. Drug Discov Today. 2009;14:1003–5.
4. Hunter J, Stephens S. Is open innovation the way forward for big pharma? Nat Rev Drug Discov. 2010;9:87–8.
5. Traitler H, Watzke HJ, Saguy IS. Reinventing R&D in an open innovation ecosystem. J Food Sci. 2011;76(2):62–8.
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Is the IPO of Bio Venture Companies Intended for R&D? Analysis Study on Listed Bio Venture Companies in Korea;Open Journal of Business and Management;2024
2. Research and development of anti-Alzheimer’s disease drugs: an update from the perspective of technology flows;Expert Opinion on Therapeutic Patents;2018-02-13
3. Evolving patterns in a collaboration network of global R&D on monoclonal antibodies;mAbs;2017-07-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3